Clinical Trial Update: Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4

View source ↗

Summary

A clinical trial evaluating visual performance of bilateral AcrySof ReSTOR Aspheric +4 intraocular lenses in cataract patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• AcrySof ReSTOR Aspheric +4 (intraocular lens)

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Status: COMPLETED